» Articles » PMID: 16225032

Milk Thistle

Overview
Specialty Public Health
Date 2005 Oct 18
PMID 16225032
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Milk thistle has been used as a cytoprotectant for the treatment of liver disease, for the treatment and prevention of cancer, and as a supportive treatment of Amanita phalloides poisoning. Clinical studies are largely heterogeneous and contradictory. Aside from mild gastrointestinal distress and allergic reactions, side effects are rare, and serious toxicity rarely has been reported. In an oral form standardized to contain 70 to 80 percent silymarin, milk thistle appears to be safe for up to 41 months of use. Significant drug reactions have not been reported. Clinical studies in oncology and infectious disease that are under way will help determine the efficacy and effectiveness of milk thistle.

Citing Articles

Silybin A from reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids.

Koeberle S, Thurmer M, Su F, Werner M, Grander J, Hofer L Theranostics. 2025; 15(5):2006-2034.

PMID: 39897559 PMC: 11780512. DOI: 10.7150/thno.99562.


Silybum marianum Extract: A Highly Effective Natural Alternative to Retinoids to Prevent Skin Aging Without Side Effects.

Boira C, Chapuis E, Lapierre L, Tiguemounine J, Scandolera A, Reynaud R J Cosmet Dermatol. 2024; 24(1):e16613.

PMID: 39692756 PMC: 11743331. DOI: 10.1111/jocd.16613.


Optimizing Production, Characterization, and In Vitro Behavior of Silymarin-Eudragit Electrosprayed Fiber for Anti-Inflammatory Effects: A Chemical Study.

Madiyar F, Suskavcevic L, Daugherty K, Weldon A, Ghate S, OBrien T Bioengineering (Basel). 2024; 11(9).

PMID: 39329606 PMC: 11428713. DOI: 10.3390/bioengineering11090864.


Chemical Standardization of Milk Thistle ( L.) Extract Using UHPLC-MS/MS and the Method of Standard Addition.

Muchiri R, van Breemen R J Am Soc Mass Spectrom. 2024; 35(8):1726-1732.

PMID: 38953246 PMC: 11311221. DOI: 10.1021/jasms.4c00125.


Glucosamine and Silibinin Alter Cartilage Homeostasis through Glycosylation and Cellular Stresses in Human Chondrocyte Cells.

Hsu Y, Huang T, Liu S, Huang S, Chen Y, Wu C Int J Mol Sci. 2024; 25(9).

PMID: 38732122 PMC: 11084729. DOI: 10.3390/ijms25094905.